Sponsor: Rubicon Genomics
Recording Date: 2/19/2014
Recording Time: 1 hour
Fluidigm Corporation, based in South San Francisco, CA, is a cutting-edge biotechnology company that develops and manufactures complete systems based on its patented microfluidic valve technology. The newly launched Single-Cell AutoPrep System enables our customers to rapidly and reliably isolate, process and profile individual cells for genomic analysis.
Fluidigm Corporation seeks an outstanding individual to join a vibrant interdisciplinary group of scientists and engineers to develop single cell analysis, sequencing, genotyping, and gene expression products.
Essential duties include, but are not limited to:
•Develop new algorithms, analysis, and assay design pipelines for targeted re-sequencing, methylation, whole genome amplification, and whole transcriptome amplification.
•Interact with collaborators and internal scientists to establish scientific relevance for novel analysis and assay design.
Ph.D. in Bioinformatics or a related field, including biological sciences, statistics, computer science, or mathematics.
•5+ years working experience in Bioinformatics
•Extensive experience with NGS technologies and sequence analysis tools.
•Understanding and hand-on experience in biostatistics and bioinformatic algorithms.
•Hand-on experience in PCR assay design.
•Good understanding biochemistry, genetics and epi-genetics.
•Proficiency in Unix/Linux, Perl, Python, R and/or MySQL.
•Highly self-motivated and enjoy working as part of a multi-disciplinary team.
•Strong analytical and problem-solving skills.
•Outstanding oral and written communication skills.
•Excellent organizational and documentation skills, thorough and detail-orientated.
Fluidigm is an equal opportunity/affirmative action employer. We will consider all qualified applicants for employment without regard to race, color, religion, sex, age, or national origin.
HR & Staffing
Fluidigm Corporation develops, manufactures, and markets microfluidic systems for academic research institutions, clinical laboratories, pharmaceutical companies, and biotechnology and Ag-Bio companies. Its proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays, and other reagents.